
TSE:HWX
This summary was created by AI, based on 5 opinions in the last 12 months.
Headwater Exploration Inc. (HWX-T) has received mixed reviews from analysts, highlighting both its strong management and successful operations in the Clearwater play. The company is credited with generating significant free cash flow and experimenting with innovative techniques such as water flooding, which have shown promising results. However, several analysts express concerns about its current valuation, suggesting that the stock trades at a notable premium compared to peers like TVE. While there is optimism for future growth, particularly in the Grand Rapids formation, the prevailing sentiment indicates that the stock might be overvalued at present levels. The overall take is that while Headwater is a well-managed company with potential upside, investors may find better opportunities elsewhere, as indicated by its current pricing and extensive asset portfolio complications.
CEO has a great reputation. Stock's not moved too much. Nice position in Clearwater, one of the best plays in Western Canada. Moving to a dividend strategy, which will increase investor interest. Assuming oil prices hold in, dividend should be well covered with cashflow and they should be able to grow production a bit.
Too small for him, but great choice of a smaller name that has torque.
His theme today is leverage, nice yield, and ability to grow cash. Growing 40% production this year, 25% next year. $100M of cash, which could grow to being 20-25% of market cap. Clean balance sheet. Can tuck in land acquisitions to build inventory. In one of the hottest plays in Canada. Very strong free cashflow. Yield is 6.39%, which could grow easily to 8-9%.
(Analysts’ price target is $9.11)
Great exposure to the WCS-WTI gap shrinking this year as the Transmountain becomes fully operational later this year. The 6% dividend will grow 10-15% this year, and they plan to grow overall by 50% over 2023. Strong cash flow as they expand. Interesting exploration plans. Fantastic results.
(Analysts’ price target is $8.88)